Denmark· DK-28104933811
Isentress
A raltegravir product containing raltegravirkalium, registered in Denmark by Merck Sharp & Dohme B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Raltegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AJ01 (raltegravir), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Raltegravir · ATC J05AJ01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of raltegravir costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Raltegravir · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$18.61
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Raltegravirkalium
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Denmark (DK)
- ATC code
- J05AJ01
- ATC class
- Raltegravir
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104933811
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for raltegravir.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Raltegravir · interactions on record
55 records
- 15 severe
- 22 moderate
- 18 minor
Most severe, free to view
- Magnesium carbonateA02AA01severe
- Magnesium hydroxideA02AA04severe
- Kombinationen von AluminiumsalzenA02AB10severe
- Calcium carbonateA02AC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AJ01
Raltegravir, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08b46fa4-34cc-4b26-a33c-5467d3462f10 GET /v1/drugs/08b46fa4-34cc-4b26-a33c-5467d3462f10?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tyggetabletter",
"source": "dkma",
"strength": "25 mg",
"auth_role": "MOD",
"dk_drugid": "28104933811",
"substance": "Raltegravirkalium",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "41330"
}See everything about raltegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.